Cullinan Oncology, Inc. to Participate in the 20th Annual Needham Virtual Healthcare Conference
Cullinan Oncology (Nasdaq: CGEM) has announced that CFO Jeff Trigilio will present at the 20th Annual Needham Virtual Healthcare Conference on April 13, 2021, at 11:45 am EDT. The presentation will be accessible only to registered attendees through the Needham conference portal. Interested investors can schedule meetings with Trigilio by contacting their Needham representative. Cullinan Oncology is focused on developing a diversified pipeline of targeted and immuno-oncology therapeutic candidates to drive shareholder returns.
- None.
- None.
CAMBRIDGE, Mass., April 07, 2021 (GLOBE NEWSWIRE) -- Cullinan Oncology, Inc. (Nasdaq: CGEM) (“Cullinan”) announced today that the company’s Chief Financial Officer, Jeff Trigilio, will present at the upcoming 20th Annual Needham Virtual Healthcare Conference.
Event: Needham Virtual Healthcare Conference
Date: Tuesday, April 13th
Time: 11:45am EDT
Location: Virtual
The presentation will be accessible through the Needham conference portal for registered attendees only. Investors interested in scheduling a meeting with Mr. Trigilio should contact their Needham & Company representative.
About Cullinan Oncology
Cullinan Oncology is a biopharmaceutical company that seeks to drive shareholder returns by focusing on the patient. The Company’s strategy is to build a diversified pipeline of targeted and immuno-oncology therapeutic candidates that are uncorrelated across multiple dimensions, with a focus on assets that it believes have novel technology, employ differentiated mechanisms, are in a more advanced stage of development than competing candidates, or have a combination of these attributes. Learn more about Cullinan at www.cullinanoncology.com.
Contacts:
Investor Relations
investors@cullinanoncology.com
Jeff Trigilio
+1 617.410.4650
jtrigilio@cullinanoncology.com
FAQ
When will Cullinan Oncology's CFO present at the Needham Conference?
How can investors attend Cullinan Oncology's presentation?
What is the focus of Cullinan Oncology?
What is the stock symbol for Cullinan Oncology?